Zyla Life Sciences Deferred Tax Liabilities, Net
Zyla Life Sciences had Deferred Tax Liabilities, Net of $20.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2020-03-26
- 2019-12-31: Deferred Tax Liabilities, Net $20.00K.
- 2018-12-31: Deferred Tax Liabilities, Net $20.00K.
- 2017-12-31: Deferred Tax Liabilities, Net $20.00K.
- 2016-12-31: Deferred Tax Liabilities, Net $23.00K.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2019-12-31 | $20.00K 10-K · filed 2020-03-26 |
| 2018-12-31 | $20.00K 10-K · filed 2020-03-26 |
| 2017-12-31 | $20.00K 10-K · filed 2019-03-29 |
| 2016-12-31 | $23.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $1.08M 10-K · filed 2017-03-13 |
| 2014-12-31 | $25.00K 10-K · filed 2016-03-11 |
| 2013-12-31 | $22.00K 10-K · filed 2015-03-16 |